Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback

However, in extended experimental designs, it may be combined with NAD+ for enhanced mitochondrial support or SS-31 for additional antioxidant protection
Many patients take this opportunity to read, listen to music, or simply unwind
Muscle preservation: Most weight lost was body fat rather than lean tissue, though some muscle loss is expected with any significant weight reduction
This peptide also is for weight loss support and thermogenic fat burning which is important for weight and fat loss
For laboratory use, it may be reconstituted with bacteriostatic water or another appropriate solvent according to established research protocols